List of Tables
Table 1. Hematologic Malignancies Testing Market Trends
Table 2. Hematologic Malignancies Testing Market Drivers & Opportunity
Table 3. Hematologic Malignancies Testing Market Challenges
Table 4. Hematologic Malignancies Testing Market Restraints
Table 5. Global Hematologic Malignancies Testing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hematologic Malignancies Testing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hematologic Malignancies Testing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hematologic Malignancies Testing Product Type
Table 9. Key Companies Time to Begin Mass Production of Hematologic Malignancies Testing
Table 10. Global Hematologic Malignancies Testing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Testing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hematologic Malignancies Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hematologic Malignancies Testing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hematologic Malignancies Testing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hematologic Malignancies Testing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hematologic Malignancies Testing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hematologic Malignancies Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hematologic Malignancies Testing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hematologic Malignancies Testing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hematologic Malignancies Testing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hematologic Malignancies Testing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hematologic Malignancies Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hematologic Malignancies Testing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hematologic Malignancies Testing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hematologic Malignancies Testing Sales Value by Region (2019-2024) & (%)
Table 27. Global Hematologic Malignancies Testing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hematologic Malignancies Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hematologic Malignancies Testing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hematologic Malignancies Testing Sales Value, (2025-2030) & (US$ Million)
Table 31. Invitae Corporation Basic Information List
Table 32. Invitae Corporation Description and Business Overview
Table 33. Invitae Corporation Hematologic Malignancies Testing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Invitae Corporation (2019-2024)
Table 35. Invitae Corporation Recent Developments
Table 36. Bio-Rad Laboratories Basic Information List
Table 37. Bio-Rad Laboratories Description and Business Overview
Table 38. Bio-Rad Laboratories Hematologic Malignancies Testing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Bio-Rad Laboratories (2019-2024)
Table 40. Bio-Rad Laboratories Recent Developments
Table 41. Sysmex Corporation Basic Information List
Table 42. Sysmex Corporation Description and Business Overview
Table 43. Sysmex Corporation Hematologic Malignancies Testing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Sysmex Corporation (2019-2024)
Table 45. Sysmex Corporation Recent Developments
Table 46. Laboratory Corporation of America Holdings Basic Information List
Table 47. Laboratory Corporation of America Holdings Description and Business Overview
Table 48. Laboratory Corporation of America Holdings Hematologic Malignancies Testing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Laboratory Corporation of America Holdings (2019-2024)
Table 50. Laboratory Corporation of America Holdings Recent Developments
Table 51. NeoGenomics Laboratories Basic Information List
Table 52. NeoGenomics Laboratories Description and Business Overview
Table 53. NeoGenomics Laboratories Hematologic Malignancies Testing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hematologic Malignancies Testing Business of NeoGenomics Laboratories (2019-2024)
Table 55. NeoGenomics Laboratories Recent Developments
Table 56. Abbott Basic Information List
Table 57. Abbott Description and Business Overview
Table 58. Abbott Hematologic Malignancies Testing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Abbott (2019-2024)
Table 60. Abbott Recent Developments
Table 61. VYANTbio Basic Information List
Table 62. VYANTbio Description and Business Overview
Table 63. VYANTbio Hematologic Malignancies Testing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hematologic Malignancies Testing Business of VYANTbio (2019-2024)
Table 65. VYANTbio Recent Developments
Table 66. Adaptive Biotechnologies Basic Information List
Table 67. Adaptive Biotechnologies Description and Business Overview
Table 68. Adaptive Biotechnologies Hematologic Malignancies Testing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Adaptive Biotechnologies (2019-2024)
Table 70. Adaptive Biotechnologies Recent Developments
Table 71. Asuragen Inc. Basic Information List
Table 72. Asuragen Inc. Description and Business Overview
Table 73. Asuragen Inc. Hematologic Malignancies Testing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Asuragen Inc. (2019-2024)
Table 75. Asuragen Inc. Recent Developments
Table 76. Invivoscribe, Inc. Basic Information List
Table 77. Invivoscribe, Inc. Description and Business Overview
Table 78. Invivoscribe, Inc. Hematologic Malignancies Testing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hematologic Malignancies Testing Business of Invivoscribe, Inc. (2019-2024)
Table 80. Invivoscribe, Inc. Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Hematologic Malignancies Testing Downstream Customers
Table 84. Hematologic Malignancies Testing Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hematologic Malignancies Testing Product Picture
Figure 2. Global Hematologic Malignancies Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 4. Hematologic Malignancies Testing Report Years Considered
Figure 5. Global Hematologic Malignancies Testing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hematologic Malignancies Testing Revenue in 2023
Figure 7. Hematologic Malignancies Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Services Picture
Figure 9. Kits Picture
Figure 10. Global Hematologic Malignancies Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Hematologic Malignancies Testing Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospitals
Figure 13. Product Picture of Specialty Clinics
Figure 14. Product Picture of Research Institutions
Figure 15. Product Picture of Others
Figure 16. Global Hematologic Malignancies Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Hematologic Malignancies Testing Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Hematologic Malignancies Testing Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Hematologic Malignancies Testing Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Hematologic Malignancies Testing Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Hematologic Malignancies Testing Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Hematologic Malignancies Testing Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Hematologic Malignancies Testing Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Hematologic Malignancies Testing Sales Value (%), (2019-2030)
Figure 29. United States Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 35. China Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 37. China Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 47. India Hematologic Malignancies Testing Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Hematologic Malignancies Testing Sales Value by Type (%), 2023 VS 2030
Figure 49. India Hematologic Malignancies Testing Sales Value by Application (%), 2023 VS 2030
Figure 50. Hematologic Malignancies Testing Industrial Chain
Figure 51. Hematologic Malignancies Testing Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
